Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tinlorafenib (PF-07284890)
i
Other names:
PF-07284890, ARRY-461, AR00504461
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Pfizer
Drug class:
BRAF inhibitor
Related drugs:
‹
vemurafenib (212)
dabrafenib (211)
PLX4720 (65)
encorafenib (63)
VS-6766 (27)
FORE-8394 (20)
RAF265 (7)
ERAS-254 (7)
GDC 0879 (6)
RXDX-105 (5)
RAF709 (3)
HI-511 (1)
SB-590885 (1)
BGB-3245 (1)
ARQ 736 (0)
ASN003 (0)
BDTX-4933 (0)
BMS-908662 (0)
PF-07799933 (0)
RX208 (0)
NSC311152 (0)
vemurafenib (212)
dabrafenib (211)
PLX4720 (65)
encorafenib (63)
VS-6766 (27)
FORE-8394 (20)
RAF265 (7)
ERAS-254 (7)
GDC 0879 (6)
RXDX-105 (5)
RAF709 (3)
HI-511 (1)
SB-590885 (1)
BGB-3245 (1)
ARQ 736 (0)
ASN003 (0)
BDTX-4933 (0)
BMS-908662 (0)
PF-07799933 (0)
RX208 (0)
NSC311152 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF V600E
Melanoma
BRAF V600E
Melanoma
PF-07284890
Sensitive: D – Preclinical
PF-07284890
Sensitive
:
D
PF-07284890
Sensitive: D – Preclinical
PF-07284890
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login